[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336265-105":59,"doc-detail-336265-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","identification-of-dna-methylation-characteristics-associated-with-metastasis-and-prognosis-in-colorectal-cancer","Identification of DNA methylation characteristics associated with metastasis and prognosis in colorectal cancer","","Colorectal cancer (CRC) frequently metastasizes and recurs after surgery, driving poor treatment outcomes and prognosis, making biomarker discovery essential. DNA methylation regulates cancer metastasis, the tumor immune microenvironment (TME), and patient prognosis, and may provide valuable predictive biomarkers for CRC. A diagnostic model and nomogram were built using differential methylation CpG sites (DMCs) between metastatic and non-metastatic patients to predict metastasis. A prognostic model based on 17 DMCs estimated progression-free survival (PFS) with medium to high accuracy, supported by immunohistochemical protein-expression differences. Immune analyses indicated lower-risk patients had better immunotherapy response. High-risk scores correlated with reduced tumor mutation burden (TMB), and high-risk patients with low TMB showed the worst PFS. The findings support clinical value of methylation markers in predicting CRC metastasis and PFS and relating these outcomes to TME, immunotherapy response, and TMB.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/identification-of-dna-methylation-characteristics-associated-with-metastasis-and-prognosis-in-colorectal-cancer/336265/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/identification-of-dna-methylation-characteristics-associated-with-metastasis-and-prognosis-in-colorectal-cancer/336265.png","ImageObject",300,407,{"name":92,"@type":93},"Aurora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are biomarkers for CRC metastasis and prognosis important?","Question",{"text":112,"@type":113},"CRC often metastasizes and recurs after surgery, contributing to poor treatment and prognosis. Biomarkers are needed to predict metastasis and outcomes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were CRC metastasis and prognosis predictions constructed?",{"text":117,"@type":113},"A diagnostic model and nomogram were built using differential methylation CpG sites (DMCs) between metastatic and non-metastatic patients. A prognostic model used 17 DMCs to predict progression-free survival (PFS).",{"name":119,"@type":110,"acceptedAnswer":120},"What relationship did the study find between methylation risk, immune response, and TMB?",{"text":121,"@type":113},"Low-risk patients showed better immunotherapy response. High-risk scores were negatively correlated with higher TMB, and high-risk patients with low TMB had the worst PFS.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336265,1790145717,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},4810365810221,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Qian et al. BMC Medical Genomics (2024) 17:127 [https://doi.org/10.1186/s12920-024-01898-4](https://doi.org/10.1186/s12920-024-01898-4)  \nBMC Medical Genomics  \n RESEARCH Open Access  \nIdentification of DNA methylation characteristics associated with metastasis and prognosis in colorectal cancer  \nFang Qian1,2, Qiang Li1, Huidan Chang1, Kai Wei1, Xiaoyi Chen2*, Tao Huang1* and Yixue Li1,3,4,5,6*  \nAbstract  \nColorectal cancer (CRC) is prone to metastasis and recurrence after surgery, which is one of the main causes for its poor treatment and prognosis. Therefore, it is essential to identify biomarkers associated with metastasis and recurrence in CRC. DNA methylation has a regulatory role in cancer metastasis, tumor immune microenvironment (TME), and prognosis and may be one of the most valuable biomarkers for predicting CRC metastasis and prognosis. We constructed a diagnostic model and nomogram that can effectively predict CRC metastasis based on the differential methylation CpG sites (DMCs) between metastatic and non-metastatic CRC patients. Then, we identified 17 DMCs associated with progression free survival (PFS) of CRC and constructed a prognostic model. The prognosis model based on 17 DMCs can predict the PFS ofCRC with medium to high accuracy. The results of immunohistochemical analysis indicated that the protein expression levels of the genes involved in prognostic DMCs were different between normal and colorectal cancer tissues. According to the results of immune-related analysis, we found  \nthat the low-risk patients had better immunotherapy response. In addition, high risk scores were negatively correlated with high tumor mutation burden (TMB) levels, and patients with low TMB levels in the high-risk group had the worst PFS. Our work shows the clinical value of DNA methylation in predicting CRC metastasis and PFS, as well as their correlation with TME, immunotherapy, and TMB, which helps understand the changes of DNA methylation in CRC metastasis and improving the treatment and prognosis of CRC.  \nKeywords Colorectal cancer (CRC), DNA methylation, Tumor immune microenvironment (TME), Tumor metastasis, Prognosis  \n*Correspondence:  \nXiaoyi Chen[chenxiaoyi@mails. ucas.ac.cn](chenxiaoyi@mails. ucas.ac.cn)[ ](chenxiaoyi@mails. ucas.ac.cn)Tao Huang [huangtao@sinh.ac.cn](huangtao@sinh.ac.cn)[ ](huangtao@sinh.ac.cn)Yixue Li  \n[yxli@sinh.ac.cn](yxli@sinh.ac.cn)  \n1 Bio-Med Big Data Center, CAS Key Laboratory of Computational Biology, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China  \n2 Guoke Ningbo Life Science and Health Industry Research Institute, Ningbo 315000, China  \n3 Key Laboratory of Systems Health Science of Zhejiang Province, School of Life Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China  \n4 Guangzhou Laboratory, Guangzhou 510005, China  \n5 School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China  \n6 Collaborative Innovation Center for Genetics and Development, Fudan University, Shanghai 200433, China  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [htt","cbCaivKgzjfhnYzT","https://ap.wps.com/l/cbCaivKgzjfhnYzT","pdf",10824647,"English","# Abstract\n## Background","[{\"question\":\"Why are biomarkers for CRC metastasis and prognosis important?\",\"answer\":\"CRC often metastasizes and recurs after surgery, contributing to poor treatment and prognosis. Biomarkers are needed to predict metastasis and outcomes.\"},{\"question\":\"How were CRC metastasis and prognosis predictions constructed?\",\"answer\":\"A diagnostic model and nomogram were built using differential methylation CpG sites (DMCs) between metastatic and non-metastatic patients. A prognostic model used 17 DMCs to predict progression-free survival (PFS).\"},{\"question\":\"What relationship did the study find between methylation risk, immune response, and TMB?\",\"answer\":\"Low-risk patients showed better immunotherapy response. High-risk scores were negatively correlated with higher TMB, and high-risk patients with low TMB had the worst PFS.\"}]","Identification of DNA methylation characteristics associated with metastasis and prognosis in colorectal cancer | PDF",1790014294,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/56029dcf70a5990589d9d2543d864f12.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ce4ce83d3d7bcc3b3a95820169e65a8b.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1fa9c303a31647f44112c5049cd2702f.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e7f24ce55984895d81d3032af9f686fe.webp",980,1301]